The market is sending conflicting signals, but the balance of evidence leans toward elevated risk rather than mispricing. A trailing P/E of 25.5 would be tolerable if growth were durable, yet the Forward P/E of 117.7 signals a dramatic earnings compression relative to current EPS of 24.6 versus next year’s estimate of $1.98. That disconnect, combined with a weak Altman Z-Score of 1.4, suggests balance sheet stress and heightened financial risk rather than hidden growth optionality. With a slim 1.90% operating margin and negative 3.30% return on equity, this is not a compounding machine—it is a structurally fragile operator priced for optimism that the fundamentals do not currently justify.